Elevated EMILIN1 expression at the tumor periphery is associated with robust CD8 T-cell infiltration, and such increased EMILIN1 expression correlates with an improved prognosis in breast cancer patients, underscoring its functional relevance in the recruitment of cytotoxic T cells to the TME (31). The gene discussed is CD8A; the disease is neoplasm.